EVOXAC Side Effects

6905635-X | Blood Sodium Decreased, Dermatitis Contact, Dry Mouth, Dry Throat, Incorrect Dose Administered, Knee Arthroplasty
on Jul 22, 2010 Female patient from UNITED STATES , 71 years of age, weighting 147.0 lb, was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and was treated with Evoxac (View Usage). Patient experienced the following unwanted or unexpected effects: blood sodium decreased, dermatitis contact, dry mouth, dry throat, incorrect dose administered, knee arthroplasty. Evoxac dosage: 90 Mg (30 Mg, Tid), Per Oral; 60 Mg (30 Mg, Bid), Per Oral. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PLAQUENIL (HYDROXYCHLOROQUINE) (HYDROXYCHLOROQUINE) (View Plaquenil (hydroxychloroquine) (hydroxychloroquine) Review and Plaquenil (hydroxychloroquine) (hydroxychloroquine) Label ), GABAPENTIN (GABAPENTIN) (GABAPENTIN) (View Gabapentin (gabapentin) (gabapentin) Review and Gabapentin (gabapentin) (gabapentin) Label ), XANAX (View Xanax Review and Xanax Label ), AMITRIPTYLINE (AMITRIPTYLINE) (AMITRIPTYLINE) (View Amitriptyline (amitriptyline) (amitriptyline) Review and Amitriptyline (amitriptyline) (amitriptyline) Label ), BUSPIRONE (BUSPIRONE) (BUSPIRONE) (View Buspirone (buspirone) (buspirone) Review and Buspirone (buspirone) (buspirone) Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ).

6844730-0 | Coronary Arterial Stent Insertion, Coronary Artery Bypass, Therapeutic Response Unexpected
Patient was taking Evoxac (View Usage). Patient had the following side effects: coronary arterial stent insertion, coronary artery bypass (What is coronary artery bypass?), therapeutic response unexpected on Jul 12, 2010 from UNITED STATES Additional patient health information: Female patient , 68 years of age, weighting 129.0 lb, was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and. Evoxac dosage: 90 Mg (30 Mg, Tid), Per Oral. During the same period patient was treated with SOTALOL (SOTALOL) (SOTALOL) (View Sotalol (sotalol) (sotalol) Review and Sotalol (sotalol) (sotalol) Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), DIOVAN (View Diovan Review and Diovan Label ), PEPCID (FAMOTIDINE (FAMOTIDINE) (View Pepcid (famotidine (famotidine) Review and Pepcid (famotidine (famotidine) Label ), PLAVIX (CLOPIDOGREL) (CLOPIDOGREL) (View Plavix (clopidogrel) (clopidogrel) Review and Plavix (clopidogrel) (clopidogrel) Label ), SALAGEN (PILOCARPINE HYDROCHLORIDE) (PILOCARPINE HYDROCHLORIDE) (View Salagen (pilocarpine Hydrochloride) (pilocarpine Hydrochloride) Review and Salagen (pilocarpine Hydrochloride) (pilocarpine Hydrochloride) Label ), NORVASC (AMLODIPINE BESILATE) (AMLODIIPNE BESILATE) (View Norvasc (amlodipine Besilate) (amlodiipne Besilate) Review and Norvasc (amlodipine Besilate) (amlodiipne Besilate) Label ). Patient was hospitalized.

6765443-X | Coronary Arterial Stent Insertion, Economic Problem
Adverse event was reported on May 31, 2010 by a Female patient taking Evoxac (View Usage) (Dosage: 90 Mg (30 Mg, Tid) Per Oral) was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and. Location: UNITED STATES , 68 years of age, weighting 129.0 lb, After Evoxac was administered, patient had the following side effects: coronary arterial stent insertion, economic problem. During the same period patient was treated with SOTALOL (View Sotalol Review and Sotalol Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), DIOVAN (View Diovan Review and Diovan Label ), PEPCID (View Pepcid Review and Pepcid Label ), PLAVIX (View Plavix Review and Plavix Label ), SALAGEN (View Salagen Review and Salagen Label ), NORVASC (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

6739013-3 | Hyperhidrosis, Rhinorrhoea
on May 24, 2010 Male patient from UNITED STATES , 64 years of age, weighting 145.0 lb, was diagnosed with dry mouth and was treated with Evoxac (View Usage). Patient experienced the following unwanted or unexpected effects: hyperhidrosis, rhinorrhoea. Evoxac dosage: 30mg 3 Times Daily Po.


6717634-1 | Delusion, Hallucination
on May 07, 2010 Male patient from UNITED STATES , weighting 145.0 lb, was diagnosed with dry mouth and was treated with Evoxac (View Usage). Patient had the following side effects: delusion, hallucination. Evoxac dosage: 30mg 3 Times A Day Po.

6692752-5 | Atrioventricular Block, Syncope
Patient was taking Evoxac (View Usage). After Evoxac was administered, patient had the following side effects: atrioventricular block, syncope on Apr 12, 2010 from UNITED STATES Additional patient health information: Male patient , 81 years of age, . Evoxac dosage: Per Oral. Patient was hospitalized.

6653011-X | Platelet Count Decreased, Systemic Lupus Erythematosus
Adverse event was reported on Nov 18, 2009 by a Female patient taking Evoxac (View Usage) (Dosage: 30 Mg, Per Oral) was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and. Location: UNITED STATES , weighting 185.0 lb, Patient experienced the following unwanted or unexpected effects: platelet count decreased, systemic lupus erythematosus. During the same period patient was treated with FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), PRILOSEC (OMEPRAZOLE) (OMEPRAZOLE) (View Prilosec (omeprazole) (omeprazole) Review and Prilosec (omeprazole) (omeprazole) Label ). Patient was hospitalized.

6535435-4 | Eye Pain, Paraesthesia, Stomatitis, Toothache
on Jan 11, 2010 Male patient from UNITED STATES , weighting 180.0 lb, was diagnosed with dry mouth and was treated with Evoxac (View Usage). Patient had the following side effects: eye pain, paraesthesia, stomatitis, toothache. Evoxac dosage: 30 Mg 3 Times A Day.

6528604-0 | Anxiety, Dry Eye, Dry Mouth, Insomnia, Muscle Twitching, Nightmare
on Jan 05, 2010 Female patient from UNITED STATES , 60 years of age, weighting 138.0 lb, was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and was treated with Evoxac (View Usage). After Evoxac was administered, patient had the following side effects: anxiety (What is anxiety?), dry eye, dry mouth, insomnia, muscle twitching, nightmare. Evoxac dosage: 30 Mg 3 X Daily Po.

6444239-2 | Dyspnoea, Product Substitution Issue
Patient was taking Evoxac (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, product substitution issue on Nov 16, 2009 from UNITED STATES Additional patient health information: Female patient , 72 years of age, . Evoxac dosage: .

6429778-2 | Malaise, Unevaluable Event
Adverse event was reported on Nov 04, 2009 by a Female patient taking Evoxac (View Usage) (Dosage: 30mg 3 Daily Po) was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and. Location: UNITED STATES , 67 years of age, weighting 160.0 lb, Patient had the following side effects: malaise, unevaluable event.

6382165-8 | Dyspnoea, Hypersensitivity, Unresponsive To Stimuli
on Sep 15, 2009 Female patient from UNITED STATES , 60 years of age, weighting 139.0 lb, was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and was treated with Evoxac (View Usage). After Evoxac was administered, patient had the following side effects: dyspnoea, hypersensitivity, unresponsive to stimuli. Evoxac dosage: 90 Mg (30 Mg, Tid), Per Oral. During the same period patient was treated with FOLIC ACID (FOLIC ACID) (1 MILLIGRAM) (FOLIC ACID) (View Folic Acid (folic Acid) (1 Milligram) (folic Acid) Review and Folic Acid (folic Acid) (1 Milligram) (folic Acid) Label ), METHOTREXATE (METHOTREXATE) (2.5 MILLIGRAM) (METHOTREXATE) (View Methotrexate (methotrexate) (2.5 Milligram) (methotrexate) Review and Methotrexate (methotrexate) (2.5 Milligram) (methotrexate) Label ), METROGEL (METRONIDAZOLE) (METRONIDAZOLE) (View Metrogel (metronidazole) (metronidazole) Review and Metrogel (metronidazole) (metronidazole) Label ), REQUIP (ROPINIROLE HYDROCHLORIDE) (1 MILLIGRAM) (ROPINIROLE HYDROCHLOR (View Requip (ropinirole Hydrochloride) (1 Milligram) (ropinirole Hydrochlor Review and Requip (ropinirole Hydrochloride) (1 Milligram) (ropinirole Hydrochlor Label ), GABITRIL (TIAGABINE HYDROCHLORIDE) (12 MILLIGRAM) (TIAGABINE HYDROCHLO (View Gabitril (tiagabine Hydrochloride) (12 Milligram) (tiagabine Hydrochlo Review and Gabitril (tiagabine Hydrochloride) (12 Milligram) (tiagabine Hydrochlo Label ), ARMOUR THYROID (THYROID) (60 MILLIGRAM) (THYROID) (View Armour Thyroid (thyroid) (60 Milligram) (thyroid) Review and Armour Thyroid (thyroid) (60 Milligram) (thyroid) Label ), CELEBREX (CELECOXIB) (100 MILLIGRAM) (CELECOXIB) (View Celebrex (celecoxib) (100 Milligram) (celecoxib) Review and Celebrex (celecoxib) (100 Milligram) (celecoxib) Label ), VIVELLE (ESTRADIOL) (0.05 MILLIGRAM) (ESTRADIOL) (View Vivelle (estradiol) (0.05 Milligram) (estradiol) Review and Vivelle (estradiol) (0.05 Milligram) (estradiol) Label ).

6338371-1 | Headache, Intracranial Hypotension, Nausea, Sciatica, Treatment Failure
on Aug 19, 2009 Female patient from UNITED STATES , 58 years of age, weighting 126.0 lb, was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and was treated with Evoxac (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?), intracranial hypotension, nausea (What is nausea?), sciatica (What is sciatica?), treatment failure. Evoxac dosage: 90 Mg (30 Mg, Tid), Per Oral. During the same period patient was treated with PROTONIX (View Protonix Review and Protonix Label ), ZOLOFT (SERTRALIEN HYDROCHLORIDE) (100 MILLIGRAM) (SERTRALINE HYDROCHL (View Zoloft (sertralien Hydrochloride) (100 Milligram) (sertraline Hydrochl Review and Zoloft (sertralien Hydrochloride) (100 Milligram) (sertraline Hydrochl Label ), CELEBREX (View Celebrex Review and Celebrex Label ), PLAQUENIL (HYDROXYCHLOROQUINE SULFATE) (HYDROXYCHLOROQUINE SULFATE) (View Plaquenil (hydroxychloroquine Sulfate) (hydroxychloroquine Sulfate) Review and Plaquenil (hydroxychloroquine Sulfate) (hydroxychloroquine Sulfate) Label ), TEMAZEPAM (TEMAZEPAM) (15 MILLIGRAM) (TEMAZEPAM) (View Temazepam (temazepam) (15 Milligram) (temazepam) Review and Temazepam (temazepam) (15 Milligram) (temazepam) Label ), FOSAMAX (ALENDRONATE SODIUM) (ALENDRONATE SODIUM) (View Fosamax (alendronate Sodium) (alendronate Sodium) Review and Fosamax (alendronate Sodium) (alendronate Sodium) Label ).

6301302-4 | Chromaturia, Nocturia, Renal Disorder, Urine Odour Abnormal
Patient was taking Evoxac (View Usage). Patient had the following side effects: chromaturia, nocturia, renal disorder, urine odour abnormal on Aug 05, 2009 from UNITED STATES Additional patient health information: Female patient , 64 years of age, weighting 270.0 lb, was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and. Evoxac dosage: 1, 3 X's, Po.

6168838-0 | Dry Mouth, Rash Erythematous, Sjogren's Syndrome
Adverse event was reported on Apr 24, 2009 by a Male patient taking Evoxac (View Usage) (Dosage: 30mg 3 Cap/day Po) was diagnosed with dry mouth, sjogren's syndrome (What is sjogren's syndrome?) and. Location: UNITED STATES , 76 years of age, weighting 196.0 lb, After Evoxac was administered, patient had the following side effects: dry mouth, rash erythematous, sjogren's syndrome (What is sjogren's syndrome?).

6044462-5 | Arrhythmia, Electrocardiogram Abnormal
on Jan 15, 2009 Female patient from UNITED STATES , weighting 126.3 lb, was treated with Evoxac (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), electrocardiogram abnormal. Evoxac dosage: 30mg Capsule 30 Mg Tid Oral. During the same period patient was treated with ALBUTEROL (View Albuterol Review and Albuterol Label ), CLOBETASOL SCALP SOLUTION (View Clobetasol Scalp Solution Review and Clobetasol Scalp Solution Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), PATANOL (View Patanol Review and Patanol Label ), SALAGEN (View Salagen Review and Salagen Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), SPECTAZOLE (View Spectazole Review and Spectazole Label ).

6002025-1 | Coronary Artery Bypass
on Dec 02, 2008 Female patient from UNITED STATES , 66 years of age, was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and was treated with Evoxac (View Usage). Patient had the following side effects: coronary artery bypass (What is coronary artery bypass?). Evoxac dosage: 2 To 3 Times Per Day, Per Oral. During the same period patient was treated with TYLENOL (PARACETAMOL) PARACETAMOL (View Tylenol (paracetamol) Paracetamol Review and Tylenol (paracetamol) Paracetamol Label ), UNITHROID(LEVOTHYROXINE SODIUM) (View Unithroid(levothyroxine Sodium) Review and Unithroid(levothyroxine Sodium) Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), LUVOX (View Luvox Review and Luvox Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), PHENERGAN (PROMETHAZINE) (View Phenergan (promethazine) Review and Phenergan (promethazine) Label ), AMBIEN (View Ambien Review and Ambien Label ), PEPCID (View Pepcid Review and Pepcid Label ). Patient was hospitalized.

5981695-8 | Cushingoid, Dry Eye, Dry Throat, Ear Pain, Joint Swelling, Lip Dry, Surgery
Patient was taking Evoxac (View Usage). After Evoxac was administered, patient had the following side effects: cushingoid, dry eye, dry throat, ear pain, joint swelling, lip dry, surgery (What is surgery?) on Nov 20, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 186.0 lb, was diagnosed with dry mouth, neuropathy peripheral and. Evoxac dosage: See Image. During the same period patient was treated with LYRICA (View Lyrica Review and Lyrica Label ), TIRCOR (FENOFIBRATE) (FENOFIBRATE) (View Tircor (fenofibrate) (fenofibrate) Review and Tircor (fenofibrate) (fenofibrate) Label ), VITAMINS (View Vitamins Review and Vitamins Label ). Patient was hospitalized.

5964617-5 | Cardiac Operation
Adverse event was reported on Nov 12, 2008 by a Female patient taking Evoxac (View Usage) (Dosage: Per Oral) was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and. Location: UNITED STATES , 66 years of age, Patient experienced the following unwanted or unexpected effects: cardiac operation. During the same period patient was treated with TYLENOIL (PARACETAMOL) (PARACETAMOL) (View Tylenoil (paracetamol) (paracetamol) Review and Tylenoil (paracetamol) (paracetamol) Label ). Patient was hospitalized.

5944280-X | Cushingoid, Dry Eye, Dry Throat, Ear Pain, Joint Swelling, Lip Dry
on Oct 24, 2008 Female patient from UNITED STATES , 84 years of age, weighting 186.0 lb, was diagnosed with dry mouth, neuropathy peripheral and was treated with Evoxac (View Usage). Patient had the following side effects: cushingoid, dry eye, dry throat, ear pain, joint swelling, lip dry. Evoxac dosage: 9- Mg (30 Mg, Tid), Per Oral. During the same period patient was treated with LYRICA (View Lyrica Review and Lyrica Label ), TRICOR (View Tricor Review and Tricor Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ). Patient was hospitalized.

5676490-3 | Dyspnoea, Tachycardia, Wheezing
on Feb 05, 2007 Female patient from UNITED STATES , 37 years of age, weighting 142.0 lb, was diagnosed with dry mouth and was treated with Evoxac (View Usage). After Evoxac was administered, patient had the following side effects: dyspnoea, tachycardia, wheezing. Evoxac dosage: 2 Doses (30 Mg) , Per Oral.

5442081-2 | Atrial Fibrillation
Patient was taking Evoxac (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?) on Aug 20, 2007 from UNITED STATES Additional patient health information: Male patient , 72 years of age, weighting 170.0 lb, was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and. Evoxac dosage: Per Oral. During the same period patient was treated with TAMBOCOR (FLECAINIDE ACETATE) (150) (FLECAINIDE ACETATE) (View Tambocor (flecainide Acetate) (150) (flecainide Acetate) Review and Tambocor (flecainide Acetate) (150) (flecainide Acetate) Label ), BENICAR HCT (View Benicar Hct Review and Benicar Hct Label ), COUMADIN (WARFARIN SODIUM) (7.5 MILLIGRAM) (WARFARIN SODIUM) (View Coumadin (warfarin Sodium) (7.5 Milligram) (warfarin Sodium) Review and Coumadin (warfarin Sodium) (7.5 Milligram) (warfarin Sodium) Label ), AVODART (DUTASTERIDE) (0.5) (DUTASTERIDE) (View Avodart (dutasteride) (0.5) (dutasteride) Review and Avodart (dutasteride) (0.5) (dutasteride) Label ), CRESTOR (ROSUVASTATIN) (10 MILLIGRAM) (ROSUVASTATIN) (View Crestor (rosuvastatin) (10 Milligram) (rosuvastatin) Review and Crestor (rosuvastatin) (10 Milligram) (rosuvastatin) Label ), NEXIUM (ESOMEPRAZOLE MAGNESIUM) (40 MILLIGRAM) (ESOMEPRAZOLE MAGNESIUM (View Nexium (esomeprazole Magnesium) (40 Milligram) (esomeprazole Magnesium Review and Nexium (esomeprazole Magnesium) (40 Milligram) (esomeprazole Magnesium Label ), ISOPTIN SR (VERAPAMIL HYDROCHLORIDE) (120 MILLIGRAM) (VERAPAMIL HYDROC (View Isoptin Sr (verapamil Hydrochloride) (120 Milligram) (verapamil Hydroc Review and Isoptin Sr (verapamil Hydrochloride) (120 Milligram) (verapamil Hydroc Label ).

5335968-2 | Glossodynia, Oral Discomfort, Vomiting
Adverse event was reported on Feb 23, 2006 by a Female patient taking Evoxac (View Usage) (Dosage: 90 Mg (30 Mg, 3 In 1 D), Per Oral) was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and. Location: UNITED STATES , 65 years of age, Patient had the following side effects: glossodynia, oral discomfort, vomiting.

5335967-0 | Dizziness, Dyspnoea, Hyperhidrosis, Loss Of Consciousness, Nausea, Pyrexia, Tachycardia
on Jul 21, 2006 Female patient from UNITED STATES , 78 years of age, weighting 190.0 lb, was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and was treated with Evoxac (View Usage). After Evoxac was administered, patient had the following side effects: dizziness (What is dizziness?), dyspnoea, hyperhidrosis, loss of consciousness, nausea (What is nausea?), pyrexia, tachycardia. Evoxac dosage: 90 Mg (30 Mg, 3 Doses, Per Oral. During the same period patient was treated with WARFARIN (WARFARIN) (TABLETS) (WARFARIN0 (View Warfarin (warfarin) (tablets) (warfarin0 Review and Warfarin (warfarin) (tablets) (warfarin0 Label ), ISOSORBIDE MONO (ISOSORBIDE MONONITRATE) (View Isosorbide Mono (isosorbide Mononitrate) Review and Isosorbide Mono (isosorbide Mononitrate) Label ), ZOCOR (SIMVASTATIN) (TABLETS) (SIMVASTATIN0 (View Zocor (simvastatin) (tablets) (simvastatin0 Review and Zocor (simvastatin) (tablets) (simvastatin0 Label ). Patient was hospitalized.

5335966-9 | Dyspnoea, Tachycardia, Wheezing
on Feb 05, 2007 Female patient from UNITED STATES , 37 years of age, weighting 142.0 lb, was diagnosed with dry mouth and was treated with Evoxac (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, tachycardia, wheezing. Evoxac dosage: 2 Doses (30 Mg), Per Oral.

5257642-3 | Bacterial Infection, Blood Creatine Phosphokinase Increased, Blood Creatinine Increased, Blood Pressure Decreased, Dehydration, Depressed Level Of Consciousness, Discomfort, Hepatic Function Abnormal, Hypercoagulation
Patient was taking Evoxac (View Usage). Patient had the following side effects: bacterial infection (What is bacterial infection?), blood creatine phosphokinase increased, blood creatinine increased, blood pressure decreased, dehydration, depressed level of consciousness, discomfort, hepatic function abnormal, hypercoagulation on Feb 16, 2007 from JAPAN Additional patient health information: Male patient , 76 years of age, was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and. Evoxac dosage: 90 Mg (30 Mg, 3 In 1 D) Per Oral.

5246444-X | Blood Creatine Phosphokinase Increased, Blood Creatinine Increased, Blood Pressure Decreased, Dehydration, Depressed Level Of Consciousness, Hepatic Function Abnormal, Hypercoagulation, Malaise, Nausea
Adverse event was reported on Feb 02, 2007 by a Male patient taking Evoxac (View Usage) (Dosage: 90 Mg (30 Mg, 3 In 1 D) Per Oral) was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and. Location: JAPAN , 76 years of age, After Evoxac was administered, patient had the following side effects: blood creatine phosphokinase increased, blood creatinine increased, blood pressure decreased, dehydration, depressed level of consciousness, hepatic function abnormal, hypercoagulation, malaise, nausea (What is nausea?).

5158345-6 | Interstitial Lung Disease
on Nov 02, 2006 Female patient from JAPAN , child 12 years of age, was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and was treated with Evoxac (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Evoxac dosage: 30 + 60 Mg (30 Mg, 1 In 1 D), Per Oral - See Image. During the same period patient was treated with PAROTIN (SALIVARY GLAND HORMONE (SALIVARY GLAND HORMONE) (View Parotin (salivary Gland Hormone (salivary Gland Hormone) Review and Parotin (salivary Gland Hormone (salivary Gland Hormone) Label ).

5132133-9 | Angioneurotic Oedema, Bradycardia, Cardiac Disorder, Sinus Arrhythmia
on Oct 03, 2006 Male patient from UNITED STATES , 56 years of age, weighting 193.0 lb, was diagnosed with congenital salivary gland anomaly and was treated with Evoxac (View Usage). Patient had the following side effects: angioneurotic oedema, bradycardia, cardiac disorder, sinus arrhythmia. Evoxac dosage: 90 Mg (30 Mg, 3 In 1 D), Per Oral; ^ A Few Months Ago ^. During the same period patient was treated with LISINOPRIL (1990's - Stopped) (View Lisinopril Review and Lisinopril Label ), PRAZOSIN GITS (View Prazosin Gits Review and Prazosin Gits Label ), BUSPAR (View Buspar Review and Buspar Label ), LOPID (View Lopid Review and Lopid Label ), CRESTOR (View Crestor Review and Crestor Label ), SULINDAC (View Sulindac Review and Sulindac Label ). Patient was hospitalized.

4984112-X | Arrhythmia
Patient was taking Evoxac (View Usage). After Evoxac was administered, patient had the following side effects: arrhythmia (What is arrhythmia?) on Feb 22, 2005 from GERMANY Additional patient health information: Male patient , 54 years of age, was diagnosed with dry mouth and. Evoxac dosage: 30 Mg (tid), Per Oral.

4984111-8 | Complex Partial Seizures, Hallucination
Adverse event was reported on Nov 02, 2005 by a Female patient taking Evoxac (View Usage) (Dosage: 30 Mg (tid), Per Oral) was diagnosed with dry mouth, sjogren's syndrome (What is sjogren's syndrome?) and. Location: UNITED STATES , 65 years of age, Patient experienced the following unwanted or unexpected effects: complex partial seizures, hallucination. During the same period patient was treated with DEPAKOTE (View Depakote Review and Depakote Label ), ATIVAN (View Ativan Review and Ativan Label ).

4958919-9 | Anaemia, Faeces Discoloured, Liver Disorder
on Mar 13, 2006 Male patient from JAPAN , 48 years of age, was diagnosed with sjogren's syndrome (What is sjogren's syndrome?), rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Evoxac (View Usage). Patient had the following side effects: anaemia, faeces discoloured, liver disorder. Evoxac dosage: 60 Mg (1 D), Per Oral. During the same period patient was treated with ARAVA (20 Mg, Per Oral) (View Arava Review and Arava Label ), BAYASPIRIN (ACETYLSALICYLIC ACID) (ACETYLSALICYLIC AC (View Bayaspirin (acetylsalicylic Acid) (acetylsalicylic Ac Review and Bayaspirin (acetylsalicylic Acid) (acetylsalicylic Ac Label ), PAXIL (View Paxil Review and Paxil Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), CLINORIL (SULINDAC) (SULINDAC) (View Clinoril (sulindac) (sulindac) Review and Clinoril (sulindac) (sulindac) Label ), PROMAC (POLAPREZINC) (View Promac (polaprezinc) Review and Promac (polaprezinc) Label ), ISCOTIN (ISONIAZID) (ISONIAZID) (View Iscotin (isoniazid) (isoniazid) Review and Iscotin (isoniazid) (isoniazid) Label ), SONALON (ALENDRONIC ACID) (View Sonalon (alendronic Acid) Review and Sonalon (alendronic Acid) Label ).

4907388-3 | Contusion, Road Traffic Accident
on Jan 24, 2006 Female patient from JAPAN , 52 years of age, was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and was treated with Evoxac (View Usage). After Evoxac was administered, patient had the following side effects: contusion, road traffic accident. Evoxac dosage: 30 Mg (30 Mg 1 In 1 D). During the same period patient was treated with URSO 250 (View Urso 250 Review and Urso 250 Label ), LIVACT (AMINO ACIDS NOS) (View Livact (amino Acids Nos) Review and Livact (amino Acids Nos) Label ), MAGNESIUM OXIDE (MAGNESIUM OXIDE) (View Magnesium Oxide (magnesium Oxide) Review and Magnesium Oxide (magnesium Oxide) Label ), JUVELA N (TOCOPHEROL NICTOINATE) (View Juvela-n (tocopherol Nictoinate) Review and Juvela-n (tocopherol Nictoinate) Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), METHYLCOBAL (MECOBALAMIN) (View Methylcobal (mecobalamin) Review and Methylcobal (mecobalamin) Label ). Patient was hospitalized.

4902577-6 | Laboratory Test, Road Traffic Accident
Patient was taking Evoxac (View Usage). Patient experienced the following unwanted or unexpected effects: laboratory test (What is laboratory test?), road traffic accident on Nov 07, 2005 from JAPAN Additional patient health information: Female patient , 52 years of age, was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and. Evoxac dosage: 30 (30 Mg, 1 In 1 D). During the same period patient was treated with URSO (URSODEOXYCHOLIC ACID) (URSODEOXYCHOLIC ACID) (View Urso (ursodeoxycholic Acid) (ursodeoxycholic Acid) Review and Urso (ursodeoxycholic Acid) (ursodeoxycholic Acid) Label ), LIVACT (AMINO ACIDS NOS) (AMINO ACIDS NOS) (View Livact (amino Acids Nos) (amino Acids Nos) Review and Livact (amino Acids Nos) (amino Acids Nos) Label ), MAGNESIUM OXIDE (MAGNESIUM OXIDE) (MAGNESIUM OXIDE) (View Magnesium Oxide (magnesium Oxide) (magnesium Oxide) Review and Magnesium Oxide (magnesium Oxide) (magnesium Oxide) Label ), JUVELA N (TOCOPHERYL NICOTINATE) (TOCOPHERYL NICOTINATE) (View Juvela-n (tocopheryl Nicotinate) (tocopheryl Nicotinate) Review and Juvela-n (tocopheryl Nicotinate) (tocopheryl Nicotinate) Label ), GASTER (FAMOTIDINE) (FAMOTIDINE) (View Gaster (famotidine) (famotidine) Review and Gaster (famotidine) (famotidine) Label ), LUPRAC (TORASEMIDE) (TORASEMIDE) (View Luprac (torasemide) (torasemide) Review and Luprac (torasemide) (torasemide) Label ), METHYCOBAL (MECOBALAMIN) (MECOBALAMIN) (View Methycobal (mecobalamin) (mecobalamin) Review and Methycobal (mecobalamin) (mecobalamin) Label ). Patient was hospitalized.

4869700-3 | Cerebral Infarction, Delirium, Dysphonia, Excitability, Restlessness
Adverse event was reported on Dec 08, 2005 by a Female patient taking Evoxac (View Usage) (Dosage: Per Oral) was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and. Location: JAPAN , 47 years of age, Patient had the following side effects: cerebral infarction, delirium, dysphonia, excitability, restlessness. During the same period patient was treated with ENBREL (ETANERCEPT) (ETANERCEPT) (View Enbrel (etanercept) (etanercept) Review and Enbrel (etanercept) (etanercept) Label ), RHEUMATREX (METHOTREXATE SODIUM) (METHOTREXATE SODIUM) (View Rheumatrex (methotrexate Sodium) (methotrexate Sodium) Review and Rheumatrex (methotrexate Sodium) (methotrexate Sodium) Label ), NABOAL SR( DICLOFENAC SODIUM) (DICLOFENAC SODIUM) (View Naboal Sr( Diclofenac Sodium) (diclofenac Sodium) Review and Naboal Sr( Diclofenac Sodium) (diclofenac Sodium) Label ), ACINON (NIZATIDINE) (NIZATIDINE) (View Acinon (nizatidine) (nizatidine) Review and Acinon (nizatidine) (nizatidine) Label ), SELBEX (TEPRENONE) (TEPRENONE) (View Selbex (teprenone) (teprenone) Review and Selbex (teprenone) (teprenone) Label ), BENET (RISEDRONATE SODIUM) (RISEDRONATE SODIUM) (View Benet (risedronate Sodium) (risedronate Sodium) Review and Benet (risedronate Sodium) (risedronate Sodium) Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), METHYCORAL (MECOBALAMIN) (MECOBALAMIN) (View Methycoral (mecobalamin) (mecobalamin) Review and Methycoral (mecobalamin) (mecobalamin) Label ). Patient was hospitalized.

4832722-2 | Complex Partial Seizures, Hallucination, Auditory, Impaired Driving Ability, Stomatitis, Tooth Disorder
on Nov 02, 2005 Female patient from UNITED STATES , 65 years of age, was diagnosed with dry mouth, sjogren's syndrome (What is sjogren's syndrome?) and was treated with Evoxac (View Usage). After Evoxac was administered, patient had the following side effects: complex partial seizures, hallucination, auditory, impaired driving ability, stomatitis, tooth disorder (What is tooth disorder?). Evoxac dosage: 30 Mg (tid), Per Oral. During the same period patient was treated with DEPAKOTE (View Depakote Review and Depakote Label ), ATIVAN (View Ativan Review and Ativan Label ).

4784986-1 | Complex Partial Seizures, Hallucination, Auditory, Impaired Driving Ability
on Jun 29, 2005 Female patient from UNITED STATES , 65 years of age, was diagnosed with dry mouth, sjogren's syndrome (What is sjogren's syndrome?) and was treated with Evoxac (View Usage). Patient experienced the following unwanted or unexpected effects: complex partial seizures, hallucination, auditory, impaired driving ability. Evoxac dosage: 30 Mg (tid), Per Oral. During the same period patient was treated with DEPAKOTE (View Depakote Review and Depakote Label ), ATIVAN (View Ativan Review and Ativan Label ).

4718034-6 | Bile Duct Stone, Chills, Chromaturia, Liver Function Test Abnormal, Nausea, Obstruction, Pain, Pruritus
Patient was taking Evoxac (View Usage). Patient had the following side effects: bile duct stone, chills, chromaturia, liver function test abnormal, nausea (What is nausea?), obstruction, pain (What is pain?), pruritus on Jul 18, 2005 from UNITED STATES Additional patient health information: Female patient , weighting 190.9 lb, was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and. Evoxac dosage: 1 Tid Oral. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DETROL LA (View Detrol La Review and Detrol La Label ), ALLEGRA (View Allegra Review and Allegra Label ), PLAVIX (View Plavix Review and Plavix Label ), DYAZIDE (View Dyazide Review and Dyazide Label ), PERCOCET (View Percocet Review and Percocet Label ). Patient was hospitalized.

4689583-4 | Chills, Eye Pain, Flushing, Headache, Lacrimation Increased, Pollakiuria, Rhinorrhoea
Adverse event was reported on Jun 13, 2005 by a Male patient taking Evoxac (View Usage) (Dosage: Three Times A Day) was diagnosed with dry mouth and. Location: , 71 years of age, weighting 125.0 lb, After Evoxac was administered, patient had the following side effects: chills, eye pain, flushing, headache (What is headache?), lacrimation increased, pollakiuria, rhinorrhoea. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ).

4596894-X | Lung Neoplasm Malignant, Lymphadenopathy, Pleural Effusion
on Feb 15, 2005 Female patient from , 48 years of age, was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and was treated with Evoxac (View Usage). Patient experienced the following unwanted or unexpected effects: lung neoplasm malignant, lymphadenopathy, pleural effusion. Evoxac dosage: See Image. During the same period patient was treated with PLAQUENIL (HYDROXYCHLOROQUINE SULFATE) (HYDROXYCHLOROQUINE SULFATE) (View Plaquenil (hydroxychloroquine Sulfate) (hydroxychloroquine Sulfate) Review and Plaquenil (hydroxychloroquine Sulfate) (hydroxychloroquine Sulfate) Label ). Patient was hospitalized.

4596616-2 | Condition Aggravated, Dehydration, Dyspnoea, Heat Stroke, Hypovolaemia, Orthostatic Hypotension, Postural Orthostatic Tachycardia Syndrome, Pyrexia
on Feb 14, 2005 Male patient from , 62 years of age, was treated with Evoxac (View Usage). Patient had the following side effects: condition aggravated, dehydration, dyspnoea, heat stroke, hypovolaemia, orthostatic hypotension, postural orthostatic tachycardia syndrome, pyrexia. Evoxac dosage: (qd Or Tid), Per Oral. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), ENTEX PSE (RESPAIRE SR 120) (View Entex Pse (respaire-sr-120) Review and Entex Pse (respaire-sr-120) Label ), CALCIUM WITH VITAMIN D (CALCIUM WITH VITAMIN D) (View Calcium With Vitamin D (calcium With Vitamin D) Review and Calcium With Vitamin D (calcium With Vitamin D) Label ), VITAMINS (VITAMINS) (View Vitamins (vitamins) Review and Vitamins (vitamins) Label ), NUPRIN (IBUPROFEN) (TALETS) (IBUPROFEN) (View Nuprin (ibuprofen) (talets) (ibuprofen) Review and Nuprin (ibuprofen) (talets) (ibuprofen) Label ), BENTYL (View Bentyl Review and Bentyl Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ZANAFLEX (View Zanaflex Review and Zanaflex Label ). Patient was hospitalized.

4576693-5 | Anxiety, Carotid Artery Stenosis, Dehydration, Heterophoria, Nausea, Orthostatic Hypotension, Transient Ischaemic Attack
Patient was taking Evoxac (View Usage). After Evoxac was administered, patient had the following side effects: anxiety (What is anxiety?), carotid artery stenosis, dehydration, heterophoria, nausea (What is nausea?), orthostatic hypotension, transient ischaemic attack on Jan 24, 2005 from Additional patient health information: Female patient , 53 years of age, was diagnosed with sjogren's syndrome (What is sjogren's syndrome?) and. Evoxac dosage: 3 Capsules (total), Oral. During the same period patient was treated with NAPOXEN (View Napoxen Review and Napoxen Label ). Patient was hospitalized.

4570080-1 | Abdominal Pain Upper, Adhesion, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Biliary Colic, Blood Alkaline Phosphatase Increased, Cholecystitis Acute, Cholelithiasis, Hepatic Enzyme Increased
Adverse event was reported on Jan 14, 2005 by a Female patient taking Evoxac (View Usage) (Dosage: 30 Mg (tid), Per Oral) was diagnosed with aptyalism and. Location: , 40 years of age, weighting 128.0 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain upper, adhesion (What is adhesion?), alanine aminotransferase increased, aspartate aminotransferase increased, biliary colic, blood alkaline phosphatase increased, cholecystitis acute, cholelithiasis, hepatic enzyme increased. During the same period patient was treated with PERCOCET (OXYCOCET) (PARACETAMOL, OXYCODONE HYDROCHLORIDE) (View Percocet (oxycocet) (paracetamol, Oxycodone Hydrochloride) Review and Percocet (oxycocet) (paracetamol, Oxycodone Hydrochloride) Label ). Patient was hospitalized and became disabled.

4546208-6 | Cholecystitis Acute, Cholelithiasis, Hypotension
on Dec 20, 2004 Female patient from , 40 years of age, was treated with Evoxac (View Usage). Patient had the following side effects: cholecystitis acute, cholelithiasis, hypotension. Evoxac dosage: 30 Mg, Tid, Per Oral. Patient was hospitalized.